Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL6824986 | 0.96 | L3MBTL1 (0.42) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL6664974 | 0.92 | L3MBTL1 (0.39) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL8342772 | 0.92 | TDP1 (0.39) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL28174502 | 0.89 | L3MBTL1 (0.39) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL2207325 | 0.88 | L3MBTL1 (0.48) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL28180555 | 0.88 | TDP1 (0.43) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL28162464 | 0.88 | TSHR (0.47) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL28168242 | 0.87 | PLA2G2C (0.47) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL6067595 | 0.86 | L3MBTL1 (0.47) | L3MBTL1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL7074449 | 0.85 | MAPT (0.49) | L3MBTL1MAPK1TDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001013742-A1 | ETHYL HEX-5-ENOATE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME | BUSH BOAKE ALLEN INC. (US) | 2001-03-01 | — | — | WO | claimed |
| CN-117321046-A | Indazole-based compounds and related methods of use | 阿维纳斯企业公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230097358-A1 | INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. | 2023-03-30 | — | — | US | disclosed |
| US-10544244-B2 | Bridged biphenyl phenol transition metal complexes, production and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-01-28 | — | — | US | disclosed |
| CN-110407730-A | Pyrrolidones herbicide | FMC CORP | 2019-11-05 | — | — | CN | disclosed |
| CN-106414403-B | Pyrrolidinone herbicides | FMC公司 | 2019-08-30 | — | — | CN | disclosed |
| CN-109844036-A | Crude oil ester and cyanoacrylate base concrete surface sealer | 泽菲罗斯有限公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-109641237-A | The acid catalyzed curable coating composition and relevant coating and method of vinyl compound containing 1,1- bis--activation | PPG工业俄亥俄公司 | 2019-04-16 | — | — | CN | disclosed |
| US-20190040165-A1 | Bridged Biphenyl Phenol Transition Metal Complexes, Production and Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-02-07 | — | — | US | disclosed |
| WO-2019027572-A1 | BRIDGED BIPHENYL PHENOL TRANSITION METAL COMPLEXES, PRODUCTION, AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-02-07 | — | — | WO | disclosed |
| US-20040142945-A1 | Fused heterocyclic compounds and use thereof | BRISTOL-MYERS SQUIBB COMPANY | 2004-07-22 | — | — | US | disclosed |
| WO-2004043367-A2 | FUSED HETEROCYCLIC COMPOUNDS AND USE THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-05-27 | — | — | WO | disclosed |
| WO-2001013742-A1 | ETHYL HEX-5-ENOATE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME | BUSH BOAKE ALLEN INC. (US) | 2001-03-01 | — | — | WO | disclosed |
| EP-0666262-B1 | Optically active compound, liquid crystal containing the same, liquid crystal device and display method using the same | CANON KK (JP) | 2000-08-30 | — | — | EP | disclosed |
| EP-0866705-A4 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5852045-A | Fibrinogen receptor antagonists | MERCK & CO., INC. (US) | 1998-12-22 | — | — | US | disclosed |
| US-5849217-A | Optically active compound, liquid crystal composition containing the same, liquid crystal device using the same, liquid crystal apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1998-12-15 | — | — | US | disclosed |
| EP-0866705-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997014417-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | disclosed |
| EP-0666262-A1 | Optically active compound, liquid crystal containing the same, liquid crystal device and display method using the same | CANON KABUSHIKI KAISHA (JP) | 1995-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142945-A1 | Fused heterocyclic compounds and use thereof | MCL1, NFATC1, BCR | L3MBTL1 1627/4885MAPK1 1107/4885TDP1 2352/4885 |
| US-20230097358-A1 | INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE | LRRK2, CRBN, MDM2 | L3MBTL1 243/4885MAPK1 2363/4885TDP1 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.